Sandoz, a Novartis company, is a global leader in generic pharmaceuticals and biosimilars, driving access to high-quality healthcare. Sandoz employs more than 26,000 people worldwide and supplies a broad range of affordable medicines to customers around the globe. Our portfolio comprises approximately 1,100 molecules, which accounted for 2014 sales of USD 9.6 billion.